UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Powering the dreams of people impacted by myasthenia gravis (MG)


    Do you or a loved one have myasthenia gravis (MG)?

    In the U.S., there are 35,000 to 60,000 people living with myasthenia gravis. Living with or supporting a loved one impacted by this rare disease can be challenging and that’s why UCB has launched the UCB Myasthenia Gravis ScholarshipTM.

    The UCB Myasthenia Gravis Scholarship TM is unique and aims to support people living with MG or their immediate family achieve educational or career goals at any stage of their life. This program aims to help individuals living with myasthenia gravis (MG) and their immediate family members to pursue educational opportunities and is available for studies in trade skills, college degrees, or other various disciplines and is open to all ages, academic scores, and levels of financial status.

    Applications are now open for submission at www.UCBMGSCHOLARSHIP.com

    Application materials received on or before Tuesday, April 1, 2025, will be accepted. All applicants who submit completed applications by the deadline will be notified about their status in June 2025.

    The UCB Myasthenia Gravis Scholarship™ is a trademark of the UCB Group of Companies.

    ©2024 UCB, Inc., Smyrna, GA 30080. All rights reserved.
     

    Categories
    Share:linkedin| twitter| email